In osteoblasts, our study found that XCR1 not only promoted ALP activity and the formation of mineralized nodules, but also significantly promoted the expression of marker genes for osteoblast differentiation, suggesting that XCR1 is a positive regulator of osteoblast differentiation, and might be a potential target for osteoporosis. The gene discussed is XCR1; the disease is osteoporosis.